Mode of action of iron (III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives

Journal of Laboratory and Clinical Medicine

Volumn 127, Issue 6, 1996, Pages 574-582

  Tsafack, Appolinaire ^b   Loyevsky, Mark ^b   Ponka, Prem ^b   Cabantchik, Z Ioav ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030174279     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90148-1     Document Type: Article

References (31)

1. Gordeuk VR, Brittenham GM, Thuma PE. Iron chelation as a chemotherapeutic strategy in the treatment of malaria. In: Bergeron RJ, Brittenham GM, eds. The development of iron chelators for clinical use. Boca Raton: CRC Press, 1994:111-30.
2. Raventos-Suarez C, Pollack S, Nagel RL. Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine. Am Trop Med Hyg 1980;31:919-22.
3. Hershko C, Peto TEA. Desferoxamine inhibition of malaria is independent of host iron status. J Exp Med 1988;168:375-87.
4. Loyevsky M, Cabantchik ZI. Antimalarial action of hydrophilic drugs: involvement of aqueous access routes to intracellular parasites. Mol Pharmacol 1994;45:446-52.
5. Fritsch G, Treumer J, Spira DT, Jung A. Plasmodium vinckei: suppression of mouse infections with desferrioxamine B. Exp Parasitol 1985;60:171-4.
6. Pollack S, Rossan RN, Davidson DE, Escjadillo A. Desferrioxamine suppresses Plasmodium falciparum in Aoutus monkeys. Proc Soc Exp Biol Med 1987;184:162-7.
7. Traore O, Carnevalle P, Kaptue-Noche L, et al. Preliminary report on the use of desferrioxamine in the treatment of Plasmodium falciparum malaria. Am J Hematol 1991;37: 206-8.
8. Gordeuk VR, Thuma PE, Brittenham GM, et al. Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia. Blood 1992;79:308-12.
9. Bunnag D, Poltera AA, Viravan A, Looareesuwan S, Harinasuta KT, Schindlery C. Plasmocidal effect of desferrioxamine B in human vivax or falciparum malaria from Thailand. Acta Tropica 1992;52:59-67.
10. Cabantchik ZI. Iron chelators as antimalarials. The biochemical basis of selective cytotoxicity. Parasitology Today 1995; 11:74-8.
11. Whitehead S, Peto TEA. Stage-dependent effect of desferrioxamine on growth of Plasmodium falciparum in vitro. Blood 1990;76:1250-5.
12. Cabantchik ZI, Glickstein H, Golenser J, Loyevsky M, Tsafack A. Iron chelators. Mode of action as antimalarials. Acta Haematologica (in press).
13. Scott MD, Ranz A, Kuypers FA, Lubin BH, Meshnick SR. Parasite uptake of desferrioxamine: a prerequisite for antimalarial activity. Br J Haematol 1990;75:598-602.
14. Lytton SD, Mester B, Dayan I, et al. Mode of action of iron (III) chelators as antimalarials. I. Membrane permeation properties and cytotoxic activity. Blood 1993;81:214-21.
15. Lytton SD, Mester B, Libman J, Shanzer A, Cabantchik ZI. Mode of action of iron (III) chelators as antimalarials. II. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis. Blood 1994;84:910-5.
16. Tsafack A, Golenser J, Libman J, Shanzer A, Cabantchik ZI. Mode of action of iron (III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum. Mol Pharmacol 1995;47:403-9.
17. Golenser J, Tsafack A, Libman J, Shanzer A, Cabantchik ZI. Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores. Antimicrob Agents Chemother 1995;39:61-5.
18. 59Fe. Biochim Biophys Acta 1983;757:306-15.
19. Laskey JD, Ponka P, Schulman HM. Control of heme synthesis during Friend cell differentiation: role of iron and transferrin. J Cell Physiol 1986;129:185-92.
20. Richardson DR, Tran EH, Bradshaw D, Ponka P. The potential of iron chelators of the pyridoxal isonocotinoyl hydrazone class as effective anti-proliferative agents. Blood 1995;86:4295-306.
21. Clarke CJ, Eaton JW. Hydrophobic iron chelators as new antimalarial drugs. Clin Res 1990;38:300A.
22. Ponka P, Borova J, Neuwirt J, Fuchs O. Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent. FEBS Lett 1979;97: 317-21.
23. Baker E, Richardson D, Gross S, Ponka P. Effects of hydrazones of pyridoxal, salicylaldehyde and 2-hydroxy-1-naphtylaldehyde on iron metabolism in hepatocytes in cultures. Hepatology 1992;15:492-501.
24. Loyevsky M, Lytton SD, Mester B, Libman J, Shanzer A, Cabantchik ZI. The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites. J Clin Invest 1993;91:218-24.
25. Lytton SD, Cabantchik ZI, Libman J, Shanzer A. Reversed siderophores as antimalarial agents. II. Selective scavenging of Fe(III) from parasitized erythrocytes by a fluorescent derivative of desferal. Mol Pharmacol 1991;40:584-90.
26. Trager W, Jensen JB. Continuous culture of human malaria parasites. Science 1976;193:673-5.
27. Shanzer A, Libman J, Lytton SD, Glickstein H, Cabantchik ZI. Reversed siderophores act as antimalarial agents. Proc Natl Acad Sci USA 1991;88:6585-9.
28. Ceriotti F, G Ceriotti. Improved direct specific determination of serum iron and total iron-binding capacity. Clin Chem 1980;26:327-31.
29. Rivadeneira EM, Wasserman M, Espinal C. Separation and concentration of shizonts of Plasmodium falciparum by Percoll gradients. J Protozool 1983;30:367-70.
30. Poch G, ed. Combined effects of drugs and toxic agents. Modern evaluation in theory and practice. New York: Springer-Verlag, 1993:54-66.
31. Gabay T, Ginsburg H. Hemoglobin denaturation and iron release in acidified red blood cell lysate. A possible source of iron for intraerythrocytic malaria parasites. Exp Parasitol 1993;77:261-72.